FDA approves cyclosporine A eye drop for vernal keratoconjunctivitis
August 09, 2021
Most patients with allergic disorder are children, adolescents, or young adults.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Ocular Allergy
VA and visual function go the way of ocular inflammation
August 12, 2021
Tool for quantifying measures may predict outcomes for patients.
Santen earns FDA approval for cyclosporine ophthalmic emulsion eye drops to treat vernal keratoconjunctivitis
June 25, 2021
Santen Inc. announced Thursday that the U.S. FDA has approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops to treat vernal keratoconjunctivitis (VKC).
Smartphone screening and referral increases access to care for people with eye problems
June 22, 2021
According to investigators, the system has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services.
ASCRS 2021 going live
June 17, 2021
The event, being held at the Mandalay Bay Resort and Casino in Las Vegas, is offering a full agenda for in-person attendees.
EyeGate Pharma announces first patient dosed in phase 2 ocular surface inflammation study
June 14, 2021
EyeGate Pharmaceuticals, Inc.'s lead product candidate is designed to treat dry eye disease-induced ocular surface inflammation.
Strategies to address challenging ocular infections
May 19, 2021
Delivering existing therapeutics through alternative routes may offer option.
Investigators zoom in on future of dry eye treatment
March 02, 2021
Autologous serum eye drops and blood products offer hope to patients.
The sky is the limit for allergy pipeline
February 18, 2021
Growing patient pool is driving clinical trial investment.
Study: Sore eyes a common symptom in COVID-19 patients
January 25, 2021
Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.